What’s new and what’s next for vaccines in 2026?

As the vaccines field continues to evolve, new technologies, targets, and delivery strategies are reshaping both research priorities and implementation pathways. We asked members of the Vaccine Insights Editorial Advisory Board to reflect on the areas shaping their current work and the developments they believe will influence the field in the years ahead. "Based on current trends, I expect increased focus on vaccine formulations that incorporate multiple antigens or immunogens, potentially addressing several diseases or stages within a single product." - Rajender Jena, Head Malaria Vaccines (Quality Control), Serum Institute of India Pvt Ltd, India

Authors

Institutions

Publication Details

Journal
Vaccine Insights
Published
2026-01-29
DOI
https://doi.org/10.18609/vac.2026.003
Primary Topic
Immune responses and vaccinations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

What’s new and what’s next for vaccines in 2026?

Trina Racine, Pierre A. Morgon, Christopher Ton, Cleo Kontoravdi et al.
Vaccine Insights
Immune responses and vaccinations
article

What’s new and what’s next for vaccines in 2026?

Trina Racine, Pierre A. Morgon, Christopher Ton, Cleo Kontoravdi, Tim Wong, Isis Kanevsky, Jeffrey Ulmer, Rajender Jena
article en

Abstract

As the vaccines field continues to evolve, new technologies, targets, and delivery strategies are reshaping both research priorities and implementation pathways. We asked members of the Vaccine Insights Editorial Advisory Board to reflect on the areas shaping their current work and the developments they believe will influence the field in the years ahead. "Based on current trends, I expect increased focus on vaccine formulations that incorporate multiple antigens or immunogens, potentially addressing several diseases or stages within a single product." - Rajender Jena, Head Malaria Vaccines (Quality Control), Serum Institute of India Pvt Ltd, India

Vaccine InsightsVol. 5(1)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Pfizer (United States) (US), Serum Institute of India (India) (IN), Serimmune (United States) (US), Healthcentric Advisors (US), Institut de Recherche Vaccinale (FR), Imperial College London (GB), University of Sheffield (GB)
Good health and well-being
Openalex Percentile: Top 61%
Immune responses and vaccinations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.